| Net Cash Provided by (Used in) Operating Activities |
$2,654,000 |
USD |
24% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$6,131,000 |
USD |
-26% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
450,000,000 |
shares |
-10% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
34,096,420 |
shares |
709% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$6,302,000 |
USD |
435% |
Q2 2025 |
Q2 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
-100% |
Q1 2024 |
Q1 2024 |
| Deferred Tax Assets, Valuation Allowance |
$28,513,000 |
USD |
11% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$28,513,000 |
USD |
11% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$23,936,000 |
USD |
9.2% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$944,000 |
USD |
758% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$160,271,000 |
USD |
20% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
$767,000 |
USD |
45% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$39,000 |
USD |
-94% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |